The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromes
Human Genetics · 2024-06 · 143 (6) · 761-773
DOI: 10.1007/s00439-024-02679-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Genetics, online erschienen am 24.05.2024. Verfasst von Niels Vos und 59 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, Department of Human Genetics, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: DNA Methylation, Intellectual Disability. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Genome Canada.
Abstract (Originalsprache)
Chung-Jansen syndrome is a neurodevelopmental disorder characterized by intellectual disability, behavioral problems, obesity and dysmorphic features. It is caused by pathogenic variants in the PHIP gene that encodes for the Pleckstrin homology domain-interacting protein, which is part of an epigenetic modifier protein complex. Therefore, we hypothesized that PHIP haploinsufficiency may impact genome-wide DNA methylation (DNAm). We assessed the DNAm profiles of affected individuals with pathogenic and likely pathogenic PHIP variants with Infinium Methylation EPIC arrays and report a specific and sensitive DNAm episignature biomarker for Chung–Jansen syndrome. In addition, we observed similarities between the methylation profile of Chung–Jansen syndrome and that of functionally related and clinically partially overlapping genetic disorders, White–Kernohan syndrome (caused by variants in DDB1 gene) and Börjeson–Forssman–Lehmann syndrome (caused by variants in PHF6 gene). Based on these observations we also proceeded to develop a common episignature biomarker for these disorders. These newly defined episignatures can be used as part of a multiclass episignature classifier for screening of affected individuals with rare disorders and interpretation of genetic variants of unknown clinical significance, and provide further insights into the common molecular pathophysiology of the clinically-related Chung–Jansen, Börjeson–Forssman–Lehmann and White–Kernohan syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Amsterdam UMC, Department of Human Genetics, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
- Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands.
- Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, ON, N6A 5W9, Canada.
- Department of Pathology and Laboratory Medicine, Western University, London, ON, N6A 3K7, Canada.
- Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands.
- Department of Genetics, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands.
Förderung
- Genome Canada
Zitieren
APA
Vos, N., Haghshenas, S., van der Laan, L., Russel, P. K. M., Rooney, K., Levy, M. A., Relator, R., Kerkhof, J., McConkey, H., Maas, S. M., Vissers, L. E. L. M., de Vries, B. B. A., Pfundt, R., Elting, M. W., van Hagen, J. M., Verbeek, N. E., Jongmans, M. C. J., Lakeman, P., Rumping, L., …, & van Haelst, M. M. (2024). The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromes. Human Genetics, 143(6), 761-773. https://doi.org/10.1007/s00439-024-02679-w
Vancouver
Vos N, Haghshenas S, van der Laan L, Russel PKM, Rooney K, Levy MA, et al. The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromes. Human Genetics. 2024;143(6):761-773. doi:10.1007/s00439-024-02679-w
BibTeX
@article{Vos2024,
author = {Vos, Niels and Haghshenas, Sadegheh and van der Laan, Liselot and Russel, Perle K M and Rooney, Kathleen and Levy, Michael A and Relator, Raissa and Kerkhof, Jennifer and McConkey, Haley and Maas, Saskia M and Vissers, Lisenka E L M and de Vries, Bert B A and Pfundt, Rolph and Elting, Mariet W and van Hagen, Johanna M and Verbeek, Nienke E and Jongmans, Marjolijn C J and Lakeman, Phillis and Rumping, Lynne and Bosch, Danielle G M and Vitobello, Antonio and Thauvin-Robinet, Christel and Faivre, Laurence and Nambot, Sophie and Garde, Aurore and Willems, Marjolaine and Genevieve, David and Nicolas, Gaël and Busa, Tiffany and Toutain, Annick and Gérard, Marion and Bizaoui, Varoona and Isidor, Bertrand and Merla, Giuseppe and Accadia, Maria and Schwartz, Charles E and Ounap, Katrin and Hoffer, Mariëtte J V and Nezarati, Marjan M and van den Boogaard, Marie-José H and Tedder, Matthew L and Rogers, Curtis and Brusco, Alfredo and Ferrero, Giovanni B and Spodenkiewicz, Marta and Sidlow, Richard and Mussa, Alessandro and Trajkova, Slavica and McCann, Emma and Mroczkowski, Henry J and Jansen, Sandra and Donker-Kaat, Laura and Duijkers, Floor A M and Stuurman, Kyra E and Mannens, Marcel M A M and Alders, Mariëlle and Henneman, Peter and White, Susan M and Sadikovic, Bekim and van Haelst, Mieke M},
title = {The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromes},
journal = {Human Genetics},
year = {2024},
volume = {143},
number = {6},
pages = {761--773},
doi = {10.1007/s00439-024-02679-w}
}
EUVIMED